November 13, 2025 — The American Antitrust Institute (AAI) has recognized the Innovative Health, LLC v. Biosense Webster, Inc. litigation team with the Outstanding Antitrust Litigation Achievement in Private Law Practice award. This award celebrates exceptional contributions to advancing the enforcement of antitrust laws and promoting competition.

Kellogg Hansen served as lead trial counsel, alongside Berger Montague, Jeffrey L. Berhold PC, and Theodora Oringher PC.

The case alleged that Biosense Webster, Inc. engaged in a tying arrangement and other exclusionary conduct that foreclosed competition from reprocessors of cardiac catheters. The litigation addressed monopolistic behavior in the aftermarket for reprocessed medical devices—an area rarely litigated all the way to trial under Section 2 of the Sherman Act.

The case was initially dismissed on summary judgment.  After the Ninth Circuit reversed, the team guided the case through post-remand discovery and trial, ultimately securing a successful jury verdict and $442 million in treble damages, as well as injunctive relief.

This outcome represents one of the few successful aftermarket tying verdicts in recent decades and carries significant implications for healthcare competition—reinforcing consumer choice, reducing medical costs, and contributing to the evolving jurisprudence on monopolization and tying in the medical device industry.

In addition, Kelley C. Schiffman was honored by AAI for Outstanding Antitrust Litigation Achievement by a Young Lawyer for her contributions to this case.

The Kellogg Hansen team included Derek T. Ho, Andrew E. Goldsmith, Kelley C. Schiffman, Rachel Anderson DeLisle, Annamaria M. Morales-Kimball, Matthew D. Reade, and Sean P. Quirk.

More information about the AAI Antitrust Enforcement Awards can be found here.